MGUS is per se a benign pathology which is differentiated by multiple myeloma, Waldenström's macroglobulinemia (WM), and NHLs according to the type of M-protein, its concentration, degree of bone marrow infiltration of plasma cells or lymphoplasmacytic cells, and presence of certain clinical manifestations. Here, MYOM2 is linked to plasma cell myeloma.